Skip to main content
Premium Trial:

Request an Annual Quote

Benjamin Bulkley, John Thompson, Edwin Moses, Sir Harry Solomon, Malcolm Weir

Premium

Invitrogen has appointed Benjamin Bulkley to the position of senior vice president of commercial operations. Bulkley most recently served as vice president of global services for General Electric’s Medical Systems Information Technologies division. Invitrogen has also promoted John Thompson from vice president of corporate development to senior vice president of corporate development.


Inpharmatica has appointed Edwin Moses as non-executive chairman. Moses has been a non-executive director of the company since July 2001. Sir Harry Solomon, the company’s former chairman, will remain a board director. Moses was previously CEO of Oxford Asymmetry International. Malcolm Weir, Inpharmatica CEO, said the company’s recent transition to a drug discovery business model “has brought with it the need for a chairman experienced in the healthcare sector to help management guide the company through the next stage in its evolution.”

Filed under

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.